Arboretum LifeSciences
PrivateLast Round
Series A
Oct 7, 2026
Total Funding Raised
$30M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Arboretum LifeSciences is a biotechnology company that provides a molecular information platform integrating AI, genetic testing, and clinical data to support precision medicine and clinical trial development for common diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, ML Platforms, Medical AI
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arboretum LifeSciences Comparables
Compare Arboretum LifeSciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Insitro | 79% | |
| Valo Health | 78% | |
| Verge Labs | 78% |
Arboretum LifeSciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 7, 2026 |
Arboretum LifeSciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GV | Series A |
| F-Prime Capital | Series A |
| 406 Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 7, 2026
$30M round with participation from Amgen and GV.
- Apr 11, 2025
Grew 100% QoQ from 3 to 6 employees.
Recent news
Latest coverage and updates
- receives_financingAug 1, 2026
Arboretum receives $30M Series A financing in Massachusetts in Oct '26
Arboretum LifeSciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Arboretum LifeSciences's valuation, stock price, and market status.
Is Arboretum LifeSciences a public or private company?
Arboretum LifeSciences is a private company.
What is the current stock price of Arboretum LifeSciences?
Arboretum LifeSciences is a private company, so its shares have no public market price. Caplight tracks Arboretum LifeSciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Arboretum LifeSciences worth (valuation)?
Valuation information for Arboretum LifeSciences is not publicly available.
Can I buy Arboretum LifeSciences stock?
Arboretum LifeSciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Arboretum LifeSciences's last funding round?
Arboretum LifeSciences's most recent funding round was Series A on October 7, 2026.
Who are the main investors in Arboretum LifeSciences?
Key investors in Arboretum LifeSciences include GV, F-Prime Capital, 406 Ventures.
Will Arboretum LifeSciences IPO soon?
No public IPO plans have been announced for Arboretum LifeSciences.
How can I track Arboretum LifeSciences secondary market activity?
Caplight tracks bids, offers, and trades in Arboretum LifeSciences's shares on secondary markets.